VEGFA and familial pancreatic carcinoma: MUC5AC might contribute to the progression of pancreatic cancer by inducing adhesiveness and invasiveness in ECM via VEGF overexpression, indicating that MUC5AC may be a potentially target in the treatment of pancreatic cancer.